BSE filing, NSE: HUHTAMAKI. Summary written from the filing by ALFA Finder's alert engine.
Huhtamaki India Ltd: key numbers
- Share price
- ₹229.57
- Market cap
- ₹1,734 Cr
- Revenue (annual)
- ₹2,469 Cr
- Net profit (annual)
- ₹118.2 Cr
- P/E (TTM)
- 13.4×Sector 36.4×
- Promoter holding
- 67.73%+0.00% QoQ
- FII holding
- 1.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Huhtamaki India Ltd
All →Huhtamaki India Results Update
Huhtamaki India reported Q3 2026 net sales of ₹748.1 Crore, EBIT margin 7.0%. Nine-month sales rose 15.7% to ₹2,070.4 Crore on volume growth and cost pass-through.
Huhtamaki India Q2 FY27 Results: Net Profit ₹29.7 Cr, Down 19.3% YoY
Huhtamaki India Ltd reported revenue from operations of ₹768.8 Cr (+23.1% YoY) and net profit of ₹29.7 Cr (-19.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹29.7 Cr · -19.3% YoY
Huhtamaki India Other Announcement
Huhtamaki India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Huhtamaki India Legal & Regulatory
DNH Planning Authority imposed a Rs.0.18 Crore penalty on Huhtamaki India for delayed Occupancy Certificate at its Silvassa plant. No further operational impact stated.
- Value
- ₹0.18 Cr
Huhtamaki India Adverse Business Impact
Huhtamaki India Limited will close its Baddi manufacturing facility by October 30, 2026. The operations will consolidate at Ambernath and Bangalore to improve operational efficiency.
- Value
- ₹21.88 Cr
Huhtamaki India Management Change
Huhtamaki India Limited appointed Ms. Akanksha Kandoi as the new Company Secretary and Compliance Officer, effective August 24, 2026.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.